Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III

More favourable outcomes were found in women with a biological valve compared with a mechanical valve. In women with a mechanical valve, the use of LMWH was associated with an increased risk of thromboembolic complications. A mitral prosthetic valve was identified as a predictor for valve thrombosis. The benefit could not be confirmed nor refuted, in terms of reduced thromboembolic events, from using anti-Xa level monitoring in women on LMWH.

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2025-04-01
DOI
https://doi.org/10.1093/eurheartj/ehaf265
Citations
15
Primary Topic
Cardiovascular Issues in Pregnancy
Type
article
Field-Weighted Citation Impact
20.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III

Catherine M Otto, Jolien W. Roos‐Hesselink, G. Justin Paul, Johanna A van der Zande et al.
15 citations
European Heart Journal
Cardiovascular Issues in Pregnancy
20.82
article

Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III

Catherine M Otto, Jolien W. Roos‐Hesselink, G. Justin Paul, Johanna A van der Zande, R Vasallo Peraza, Karen S Sliwa, Ariane J. Marelli, Isabelle Malhamé, Hasan Al Farhan, Karishma P. Ramlakhan, Jerome M J Cornette, Aldo P. Maggioni, Roger Hall, Mark R. Johnson
article en
15 citations

Abstract

More favourable outcomes were found in women with a biological valve compared with a mechanical valve. In women with a mechanical valve, the use of LMWH was associated with an increased risk of thromboembolic complications. A mitral prosthetic valve was identified as a predictor for valve thrombosis. The benefit could not be confirmed nor refuted, in terms of reduced thromboembolic events, from using anti-Xa level monitoring in women on LMWH.

European Heart JournalVol. 47(11)
University of East Anglia (GB), University of Baghdad (IQ), University of Cape Town (ZA), Madras Medical College (IN), University of Washington (US), Baghdad Medical City (IQ), McGill University Health Centre (CA), Erasmus MC (NL), Associazione Nazionale Medici Cardiologi Ospedalieri (IT), Havana Research Institute (US), Erasmus MC - Sophia Children’s Hospital (NL), Imperial College London (GB), Erasmus University Rotterdam (NL)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, Sanofi, Boston Scientific Corporation, ResMed, Gedeon Richter, Stichting Zabawas, Servier, Novartis Pharma, Abbott Vascular, Daiichi Sankyo Europe
Openalex Percentile: Top 0%
Cardiovascular Issues in Pregnancy
20.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.